HK Stock MarketDetailed Quotes

01528 RS MACALLINE

Watchlist
  • 1.560
  • 0.0000.00%
Not Open May 2 16:08 CST
6.79BMarket Cap-2085P/E (TTM)

RS MACALLINE Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
(Q9)Sep 30, 2021
Cash flow from operating activities
Earning before tax
-258.96%-2.54B
----
-83.26%288.2M
----
-40.48%1.6B
----
--1.72B
----
--2.68B
----
Profit adjustment
Interest (income) - adjustment
27.43%-167.32M
----
33.33%-79.57M
----
-1.49%-230.57M
----
---119.36M
----
---227.2M
----
Dividend (income)- adjustment
-25.32%-53.68M
----
-201.75%-34.54M
----
-1,198.09%-42.84M
----
---11.45M
----
---3.3M
----
Attributable subsidiary (profit) loss
-393.97%-77.7M
----
-142.86%-88.77M
----
158.49%26.43M
----
---36.55M
----
---45.19M
----
Impairment and provisions:
95.48%1.88B
--0
48.85%252.25M
--0
27.52%960.03M
--0
--169.47M
--0
--752.84M
--0
-Impairmen of inventory (reversal)
--92.14M
----
----
----
----
----
----
----
----
----
-Other impairments and provisions
85.88%1.78B
----
48.85%252.25M
----
27.52%960.03M
----
--169.47M
----
--752.84M
----
Revaluation surplus:
113.78%1.59B
--0
48.12%323.03M
--0
198.33%744.03M
--0
--218.08M
--0
--249.4M
--0
-Fair value of investment properties (increase)
113.00%1.55B
----
30.83%296.25M
----
194.19%725.83M
----
--226.43M
----
--246.73M
----
-Other fair value changes
144.84%44.56M
----
420.76%26.78M
----
581.90%18.2M
----
---8.35M
----
--2.67M
----
Asset sale loss (gain):
2,643.90%88.83M
--0
676.59%51.15M
--0
99.31%-3.49M
--0
--6.59M
--0
---504.15M
--0
-Loss (gain) from sale of subsidiary company
26,455.93%77.75M
----
392.21%35.9M
----
99.94%-295K
----
--7.29M
----
---487.88M
----
-Loss (gain) on sale of property, machinery and equipment
446.07%11.06M
----
2,256.86%15.25M
----
76.46%-3.2M
----
---707K
----
---13.58M
----
-Loss (gain) from selling other assets
--19K
----
----
----
----
----
----
----
---2.69M
----
Depreciation and amortization:
-14.12%318.14M
--0
-7.90%173.22M
--0
-9.70%370.43M
--0
--188.07M
--0
--410.22M
--0
-Depreciation
-16.04%277.28M
----
-9.14%152.8M
----
-8.71%330.25M
----
--168.17M
----
--361.78M
----
-Amortization of intangible assets
1.68%40.86M
----
2.59%20.42M
----
-17.05%40.18M
----
--19.91M
----
--48.44M
----
Financial expense
6.04%2.65B
----
0.51%1.26B
----
-7.10%2.5B
----
--1.25B
----
--2.69B
----
Exchange Loss (gain)
--29.49M
----
----
----
----
----
----
----
----
----
Special items
197.38%51.9M
----
--48.41M
----
-158.62%-53.3M
----
----
----
--90.92M
----
Operating profit before the change of operating capital
-35.76%3.77B
--0
-35.33%2.19B
--0
-3.78%5.87B
--0
--3.39B
--0
--6.1B
--0
Change of operating capital
Inventory (increase) decrease
62.83%42.69M
----
889.21%31.63M
----
3,410.48%26.22M
----
--3.2M
----
---792K
----
Accounts receivable (increase)decrease
403.71%625.47M
----
475.17%262.27M
----
-127.03%-205.94M
----
---69.91M
----
--761.87M
----
Accounts payable increase (decrease)
-3.09%-346.66M
----
85.00%-64.47M
----
66.42%-336.27M
----
---429.86M
----
---1B
----
Advance payment increase (decrease)
100.37%2.99M
----
139.87%314.8M
----
-211.88%-818.82M
----
---789.66M
----
--731.89M
----
Cash  from business operations
-25.47%3.09B
--0
4.41%2.3B
--0
-30.89%4.14B
--0
--2.2B
--0
--5.99B
--0
Other taxs
-175.74%-722.7M
----
-15.00%-230.09M
----
57.12%-262.09M
----
---200.07M
----
---611.25M
----
Special items of business
-155.21%-1.01B
----
-540.66%-437.28M
----
34.24%-395.8M
----
--99.23M
----
---601.88M
----
Net cash from operations
-39.07%2.36B
-30.37%2.77B
3.35%2.07B
-14.59%1.08B
-27.91%3.88B
-16.72%3.98B
-3.96%2B
71.14%1.26B
29.35%5.38B
128.98%4.77B
Cash flow from investment activities
Interest received - investment
-95.00%11.53M
----
-75.67%9.36M
----
1.49%230.57M
----
--38.48M
----
--227.2M
----
Dividend received - investment
111.37%90.54M
----
144.11%44.88M
----
298.74%42.84M
----
--18.39M
----
--10.74M
----
Loan receivable (increase) decrease
-13,925.62%-186.68M
----
21.01%6.06M
----
-100.53%-1.33M
----
--5.01M
----
--252.2M
----
Decrease in deposits (increase)
-130.61%-148.62M
----
-112.91%-34.21M
----
343.07%485.52M
----
--265.02M
----
---199.75M
----
Sale of fixed assets
147.47%120.27M
----
6,586.14%118.68M
----
117.42%48.6M
----
-90.73%1.78M
----
81.83%22.35M
----
Purchase of fixed assets
80.04%-40.24M
----
89.51%-44.58M
----
53.40%-201.6M
----
69.51%-425.08M
----
85.07%-432.57M
----
Selling intangible assets
-98.28%235K
----
--306K
----
6,292.06%13.68M
----
----
----
--214K
----
Purchase of intangible assets
96.03%-1.34M
----
-1,458.28%-15.05M
----
-333.92%-33.8M
----
---966K
----
---7.79M
----
Sale of subsidiaries
370.18%633.97M
----
989.88%81.52M
----
-74.68%134.83M
----
-95.36%7.48M
----
53,248,699,900.00%532.49M
----
Acquisition of subsidiaries
---12.5M
----
----
----
----
----
22.58%-5.5M
----
66.02%-544.1M
----
Recovery of cash from investments
-84.57%491.98M
----
-27.20%851.77M
----
-37.31%3.19B
----
118.61%1.17B
----
205.63%5.09B
----
Cash on investment
61.95%-309.73M
----
41.68%-196.2M
----
79.97%-814.01M
----
-66.49%-336.44M
----
-394.60%-4.06B
----
Other items in the investment business
102.16%51.94M
----
86.58%-88.06M
----
-138.30%-2.41B
----
-177.49%-656.3M
----
16.44%-1.01B
----
Net cash from investment operations
1.99%701.36M
214.35%536M
797.67%734.47M
-42.78%232.66M
642.29%687.7M
-91.98%170.51M
301.74%81.82M
262.58%406.62M
97.39%-126.81M
138.90%2.13B
Net cash before financing
-32.88%3.07B
-20.30%3.3B
34.55%2.8B
-21.47%1.31B
-13.08%4.57B
-39.91%4.15B
1.95%2.08B
242.82%1.67B
859.15%5.25B
304.18%6.9B
Cash flow from financing activities
New borrowing
9.44%12.21B
----
-66.11%2.59B
----
-22.24%11.16B
----
23.77%7.63B
----
-22.89%14.35B
----
Refund
5.29%-12.18B
----
50.20%-3.49B
----
21.02%-12.86B
----
17.68%-7B
----
-11.48%-16.28B
----
Issuing shares
----
----
----
----
----
----
----
----
--3.68B
----
Issuance of bonds
----
----
----
----
--1.7B
----
----
----
----
----
Interest paid - financing
10.85%-2.22B
----
15.72%-1.25B
----
0.40%-2.49B
----
---1.48B
----
---2.5B
----
Dividends paid - financing
70.79%-167.78M
----
76.54%-17.21M
----
-168.73%-574.31M
----
94.96%-73.35M
----
94.36%-213.72M
----
Absorb investment income
11,088.83%305.46M
----
----
----
-96.50%2.73M
----
-96.71%2.23M
----
293.14%78.04M
----
Issuance expenses and redemption of securities expenses
87.17%-530.83M
----
66.61%-500.83M
----
-3.06%-4.14B
----
---1.5B
----
---4.01B
----
Other items of the financing business
31.83%-582.45M
----
-51.42%-247.27M
----
-481.20%-854.4M
----
-181.24%-163.3M
----
64.44%-147.01M
----
Net cash from financing operations
60.72%-3.17B
44.70%-2.79B
-12.63%-2.91B
21.76%-1.5B
-59.47%-8.06B
28.30%-5.05B
26.71%-2.59B
-128.37%-1.92B
-2,678.28%-5.05B
-455.32%-7.05B
Effect of rate
-118.05%-510K
-78.75%351.58K
1,283.02%627K
25.24%-736.13K
185.66%2.83M
1,128.30%1.65M
85.38%-53K
-126.83%-984.63K
-209.77%-3.3M
97.14%-160.9K
Net Cash
97.11%-100.95M
156.31%509.99M
78.06%-110.47M
23.70%-193.15M
-1,844.33%-3.49B
-509.95%-905.67M
66.13%-503.52M
27.76%-253.13M
122.88%200.22M
89.40%-148.48M
Begining period cash
-57.23%2.61B
-57.23%2.61B
-57.23%2.61B
-57.23%2.61B
3.34%6.1B
3.34%6.1B
3.34%6.1B
3.34%6.1B
-12.91%5.9B
-12.91%5.9B
Cash at the end
-3.89%2.51B
-39.94%3.12B
-55.34%2.5B
-58.68%2.42B
-57.23%2.61B
-9.74%5.19B
26.73%5.59B
5.30%5.84B
3.34%6.1B
7.03%5.75B
Cash balance analysis
Cash and cash equivalent balance
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
IAS
CAS (2007)
IAS
CAS (2007)
IAS
CAS (2007)
IAS
CAS (2007)
IAS
CAS (2007)
Audit Opinions
Unqualified Opinion
--
--
--
Unqualified Opinion
--
--
--
Unqualified Opinion
--
Auditor
National Health Certified Public Accountants Limited, ZTE Caiguanghua Certified Public Accountants (Special General Partnership)
--
--
--
National Health Certified Public Accountants Limited, ZTE Caiguanghua Certified Public Accountants (Special General Partnership)
--
--
--
National Health Certified Public Accountants Limited, ZTE Caiguanghua Certified Public Accountants (Special General Partnership)
--
(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021(Q9)Sep 30, 2021
Cash flow from operating activities
Earning before tax -258.96%-2.54B-----83.26%288.2M-----40.48%1.6B------1.72B------2.68B----
Profit adjustment
Interest (income) - adjustment 27.43%-167.32M----33.33%-79.57M-----1.49%-230.57M-------119.36M-------227.2M----
Dividend (income)- adjustment -25.32%-53.68M-----201.75%-34.54M-----1,198.09%-42.84M-------11.45M-------3.3M----
Attributable subsidiary (profit) loss -393.97%-77.7M-----142.86%-88.77M----158.49%26.43M-------36.55M-------45.19M----
Impairment and provisions: 95.48%1.88B--048.85%252.25M--027.52%960.03M--0--169.47M--0--752.84M--0
-Impairmen of inventory (reversal) --92.14M------------------------------------
-Other impairments and provisions 85.88%1.78B----48.85%252.25M----27.52%960.03M------169.47M------752.84M----
Revaluation surplus: 113.78%1.59B--048.12%323.03M--0198.33%744.03M--0--218.08M--0--249.4M--0
-Fair value of investment properties (increase) 113.00%1.55B----30.83%296.25M----194.19%725.83M------226.43M------246.73M----
-Other fair value changes 144.84%44.56M----420.76%26.78M----581.90%18.2M-------8.35M------2.67M----
Asset sale loss (gain): 2,643.90%88.83M--0676.59%51.15M--099.31%-3.49M--0--6.59M--0---504.15M--0
-Loss (gain) from sale of subsidiary company 26,455.93%77.75M----392.21%35.9M----99.94%-295K------7.29M-------487.88M----
-Loss (gain) on sale of property, machinery and equipment 446.07%11.06M----2,256.86%15.25M----76.46%-3.2M-------707K-------13.58M----
-Loss (gain) from selling other assets --19K-------------------------------2.69M----
Depreciation and amortization: -14.12%318.14M--0-7.90%173.22M--0-9.70%370.43M--0--188.07M--0--410.22M--0
-Depreciation -16.04%277.28M-----9.14%152.8M-----8.71%330.25M------168.17M------361.78M----
-Amortization of intangible assets 1.68%40.86M----2.59%20.42M-----17.05%40.18M------19.91M------48.44M----
Financial expense 6.04%2.65B----0.51%1.26B-----7.10%2.5B------1.25B------2.69B----
Exchange Loss (gain) --29.49M------------------------------------
Special items 197.38%51.9M------48.41M-----158.62%-53.3M--------------90.92M----
Operating profit before the change of operating capital -35.76%3.77B--0-35.33%2.19B--0-3.78%5.87B--0--3.39B--0--6.1B--0
Change of operating capital
Inventory (increase) decrease 62.83%42.69M----889.21%31.63M----3,410.48%26.22M------3.2M-------792K----
Accounts receivable (increase)decrease 403.71%625.47M----475.17%262.27M-----127.03%-205.94M-------69.91M------761.87M----
Accounts payable increase (decrease) -3.09%-346.66M----85.00%-64.47M----66.42%-336.27M-------429.86M-------1B----
Advance payment increase (decrease) 100.37%2.99M----139.87%314.8M-----211.88%-818.82M-------789.66M------731.89M----
Cash  from business operations -25.47%3.09B--04.41%2.3B--0-30.89%4.14B--0--2.2B--0--5.99B--0
Other taxs -175.74%-722.7M-----15.00%-230.09M----57.12%-262.09M-------200.07M-------611.25M----
Special items of business -155.21%-1.01B-----540.66%-437.28M----34.24%-395.8M------99.23M-------601.88M----
Net cash from operations -39.07%2.36B-30.37%2.77B3.35%2.07B-14.59%1.08B-27.91%3.88B-16.72%3.98B-3.96%2B71.14%1.26B29.35%5.38B128.98%4.77B
Cash flow from investment activities
Interest received - investment -95.00%11.53M-----75.67%9.36M----1.49%230.57M------38.48M------227.2M----
Dividend received - investment 111.37%90.54M----144.11%44.88M----298.74%42.84M------18.39M------10.74M----
Loan receivable (increase) decrease -13,925.62%-186.68M----21.01%6.06M-----100.53%-1.33M------5.01M------252.2M----
Decrease in deposits (increase) -130.61%-148.62M-----112.91%-34.21M----343.07%485.52M------265.02M-------199.75M----
Sale of fixed assets 147.47%120.27M----6,586.14%118.68M----117.42%48.6M-----90.73%1.78M----81.83%22.35M----
Purchase of fixed assets 80.04%-40.24M----89.51%-44.58M----53.40%-201.6M----69.51%-425.08M----85.07%-432.57M----
Selling intangible assets -98.28%235K------306K----6,292.06%13.68M--------------214K----
Purchase of intangible assets 96.03%-1.34M-----1,458.28%-15.05M-----333.92%-33.8M-------966K-------7.79M----
Sale of subsidiaries 370.18%633.97M----989.88%81.52M-----74.68%134.83M-----95.36%7.48M----53,248,699,900.00%532.49M----
Acquisition of subsidiaries ---12.5M--------------------22.58%-5.5M----66.02%-544.1M----
Recovery of cash from investments -84.57%491.98M-----27.20%851.77M-----37.31%3.19B----118.61%1.17B----205.63%5.09B----
Cash on investment 61.95%-309.73M----41.68%-196.2M----79.97%-814.01M-----66.49%-336.44M-----394.60%-4.06B----
Other items in the investment business 102.16%51.94M----86.58%-88.06M-----138.30%-2.41B-----177.49%-656.3M----16.44%-1.01B----
Net cash from investment operations 1.99%701.36M214.35%536M797.67%734.47M-42.78%232.66M642.29%687.7M-91.98%170.51M301.74%81.82M262.58%406.62M97.39%-126.81M138.90%2.13B
Net cash before financing -32.88%3.07B-20.30%3.3B34.55%2.8B-21.47%1.31B-13.08%4.57B-39.91%4.15B1.95%2.08B242.82%1.67B859.15%5.25B304.18%6.9B
Cash flow from financing activities
New borrowing 9.44%12.21B-----66.11%2.59B-----22.24%11.16B----23.77%7.63B-----22.89%14.35B----
Refund 5.29%-12.18B----50.20%-3.49B----21.02%-12.86B----17.68%-7B-----11.48%-16.28B----
Issuing shares ----------------------------------3.68B----
Issuance of bonds ------------------1.7B--------------------
Interest paid - financing 10.85%-2.22B----15.72%-1.25B----0.40%-2.49B-------1.48B-------2.5B----
Dividends paid - financing 70.79%-167.78M----76.54%-17.21M-----168.73%-574.31M----94.96%-73.35M----94.36%-213.72M----
Absorb investment income 11,088.83%305.46M-------------96.50%2.73M-----96.71%2.23M----293.14%78.04M----
Issuance expenses and redemption of securities expenses 87.17%-530.83M----66.61%-500.83M-----3.06%-4.14B-------1.5B-------4.01B----
Other items of the financing business 31.83%-582.45M-----51.42%-247.27M-----481.20%-854.4M-----181.24%-163.3M----64.44%-147.01M----
Net cash from financing operations 60.72%-3.17B44.70%-2.79B-12.63%-2.91B21.76%-1.5B-59.47%-8.06B28.30%-5.05B26.71%-2.59B-128.37%-1.92B-2,678.28%-5.05B-455.32%-7.05B
Effect of rate -118.05%-510K-78.75%351.58K1,283.02%627K25.24%-736.13K185.66%2.83M1,128.30%1.65M85.38%-53K-126.83%-984.63K-209.77%-3.3M97.14%-160.9K
Net Cash 97.11%-100.95M156.31%509.99M78.06%-110.47M23.70%-193.15M-1,844.33%-3.49B-509.95%-905.67M66.13%-503.52M27.76%-253.13M122.88%200.22M89.40%-148.48M
Begining period cash -57.23%2.61B-57.23%2.61B-57.23%2.61B-57.23%2.61B3.34%6.1B3.34%6.1B3.34%6.1B3.34%6.1B-12.91%5.9B-12.91%5.9B
Cash at the end -3.89%2.51B-39.94%3.12B-55.34%2.5B-58.68%2.42B-57.23%2.61B-9.74%5.19B26.73%5.59B5.30%5.84B3.34%6.1B7.03%5.75B
Cash balance analysis
Cash and cash equivalent balance --0--0--0--0--0--0--0--0--0--0
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards IASCAS (2007)IASCAS (2007)IASCAS (2007)IASCAS (2007)IASCAS (2007)
Audit Opinions Unqualified Opinion------Unqualified Opinion------Unqualified Opinion--
Auditor National Health Certified Public Accountants Limited, ZTE Caiguanghua Certified Public Accountants (Special General Partnership)------National Health Certified Public Accountants Limited, ZTE Caiguanghua Certified Public Accountants (Special General Partnership)------National Health Certified Public Accountants Limited, ZTE Caiguanghua Certified Public Accountants (Special General Partnership)--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
%Chg